Artivion, Inc. (AORT) is a Medical - Devices company in the Healthcare sector, currently trading at $37.95. It has a SharesGrow Score of 60/100, indicating a above average investment profile with 3 out of 7 criteria passed.
SharesGrow calculates the intrinsic value of AORT = $123.97 (+226.7% from the current price, the stock appears undervalued). Analyst consensus target is AORT = $52 (+37% upside).
Valuation: AORT trades at a trailing Price-to-Earnings (P/E) of 174.4 (S&P 500 average ~25) with a forward Price/Earnings-to-Growth (PEG) of 1.56.
Financials: revenue is $441M, +12.1%/yr average growth. Net income is $10M, growing at +56.6%/yr. Net profit margin is 2.2% (thin). Gross margin is 61.3% (-3.2 pp trend).
Balance sheet: total debt is $292M against $448M equity (Debt-to-Equity (D/E) ratio 0.65, moderate). Current ratio is 2.99 (strong liquidity). Debt-to-assets is 33%. Total assets: $885M.
Analyst outlook: 10 / 12 analysts rate AORT as buy (83%) — strong consensus.
SharesGrow 7-Criteria breakdown: Value 67/100 (Pass), Growth 90/100 (Pass), Past 25/100 (Fail), Health 50/100 (Partial), Moat 61/100 (Partial), Future 94/100 (Pass), Income 30/100 (Fail).
